ZIM Laboratories Dividends and Buybacks
Dividend criteria checks 0/6
ZIM Laboratories does not currently pay a dividend.
Key information
0%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹0.167 |
| Payout ratio | 0% |
Recent dividend and buyback updates
No updates
Recent updates
ZIM Laboratories (NSE:ZIMLAB) Has A Somewhat Strained Balance Sheet
Nov 14
ZIM Laboratories' (NSE:ZIMLAB) Anemic Earnings Might Be Worse Than You Think
May 21Earnings Not Telling The Story For ZIM Laboratories Limited (NSE:ZIMLAB) After Shares Rise 28%
Apr 26ZIM Laboratories Limited's (NSE:ZIMLAB) Shares May Have Run Too Fast Too Soon
Feb 20Estimating The Fair Value Of ZIM Laboratories Limited (NSE:ZIMLAB)
May 16Sentiment Still Eluding ZIM Laboratories Limited (NSE:ZIMLAB)
Nov 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ZIMLAB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ZIMLAB's dividend payments have been increasing.
Dividend Yield vs Market
| ZIM Laboratories Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ZIMLAB) | 0% |
| Market Bottom 25% (IN) | 0.2% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (ZIMLAB) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate ZIMLAB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ZIMLAB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: ZIMLAB is not paying a notable dividend for the Indian market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ZIMLAB has not reported any payouts.